125 related articles for article (PubMed ID: 29705778)
1. Indacaterol/Glycopyrronium in Clinical Practice: The Italian Experience.
Cazzola M
Respiration; 2018; 95 Suppl 1():1-2. PubMed ID: 29705778
[No Abstract] [Full Text] [Related]
2. Coexisting Heart Failure and Chronic Obstructive Pulmonary Disease: Report of Two Cases Treated with Indacaterol/Glycopyrronium.
Cosentino ER; Degli Esposti D; Miceli R; Bentivenga C; Landolfo M; Ricci Iamino I; Spinardi L; Magri G; Borghi C
Respiration; 2018; 95 Suppl 1():3-5. PubMed ID: 29705784
[TBL] [Abstract][Full Text] [Related]
3. [The combination of indacaterol and glycopyrronium has effects on symptoms, lung function, and rate of exacerbations in COPD patients].
Ulrik CS
Ugeskr Laeger; 2014 Sep; 176(38):. PubMed ID: 25294211
[TBL] [Abstract][Full Text] [Related]
4. Indacaterol/glycopyrronium: a dual bronchodilator for COPD.
Banerji D; Fogel R; Patalano F
Drug Discov Today; 2018 Jan; 23(1):196-203. PubMed ID: 29079130
[TBL] [Abstract][Full Text] [Related]
5. Another Choice for Prevention of COPD Exacerbations.
Donohue JF
N Engl J Med; 2016 Jun; 374(23):2284-6. PubMed ID: 27181835
[No Abstract] [Full Text] [Related]
6. Indacaterol/Glycopyrronium in the Treatment of Severe Respiratory Failure: Marked Improvement of Respiratory Failure in a Few Weeks - A Case Report.
Pistelli R; Castriotti MR; Panico L
Respiration; 2018; 95 Suppl 1():19-21. PubMed ID: 29705782
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety.
Ridolo E; Montagni M; Riario-Sforza GG; Baroni M; Incorvaia C
Ther Adv Respir Dis; 2015 Apr; 9(2):49-55. PubMed ID: 25691493
[TBL] [Abstract][Full Text] [Related]
8. Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
Wedzicha JA; Banerji D; Chapman KR; Vestbo J; Roche N; Ayers RT; Thach C; Fogel R; Patalano F; Vogelmeier CF;
N Engl J Med; 2016 Jun; 374(23):2222-34. PubMed ID: 27181606
[TBL] [Abstract][Full Text] [Related]
9. [Dual bronchodilators becomes the first choice combination].
Einecke D
MMW Fortschr Med; 2016 Jun; 158(11):18. PubMed ID: 27271388
[No Abstract] [Full Text] [Related]
10. The Respiratory "Overlap Syndrome": Efficacy and Usefulness of the Combined Double Bronchodilation.
Petrone A; Fimognari FL; Mormile F; Fuso L; Quartieri M; Petrone L; Romano F
Respiration; 2018; 95 Suppl 1():15-18. PubMed ID: 29705781
[TBL] [Abstract][Full Text] [Related]
11. When Two Drugs Are Better than Three: Re-Modulating the Therapeutic Plan of a Chronic Obstructive Pulmonary Disease Patient.
Ielpo A; Crisafulli E
Respiration; 2018; 95 Suppl 1():6-10. PubMed ID: 29705779
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Indacaterol/Glycopyrronium (IND/GLY) Versus Salmeterol/Fluticasone in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: The Chinese Cohort from the LANTERN Study.
Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Patalano F; Banerji D
COPD; 2016 Dec; 13(6):686-692. PubMed ID: 27715335
[TBL] [Abstract][Full Text] [Related]
13. GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.
Worth H; Buhl R; Criée CP; Kardos P; Lossi NS; Vogelmeier CF
Respir Med; 2017 Oct; 131():77-84. PubMed ID: 28947047
[TBL] [Abstract][Full Text] [Related]
14. The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.
Blais CM; Davis BE; Cockcroft DW
Respir Res; 2017 Aug; 18(1):146. PubMed ID: 28768531
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease.
Cazzola M; Rogliani P
J Comp Eff Res; 2017 Oct; 6(7):627-636. PubMed ID: 28840753
[TBL] [Abstract][Full Text] [Related]
16. FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease.
Mahler DA; Kerwin E; Ayers T; FowlerTaylor A; Maitra S; Thach C; Lloyd M; Patalano F; Banerji D
Am J Respir Crit Care Med; 2015 Nov; 192(9):1068-79. PubMed ID: 26177074
[TBL] [Abstract][Full Text] [Related]
17. Indacaterol-Glycopyrronium for COPD.
Franssen FM; Wouters EF; Vanfleteren LE
N Engl J Med; 2016 Sep; 375(9):898-9. PubMed ID: 27579650
[No Abstract] [Full Text] [Related]
18. Indacaterol-Glycopyrronium for COPD.
Contoli M; Morelli P; Papi A
N Engl J Med; 2016 Sep; 375(9):898. PubMed ID: 27579649
[No Abstract] [Full Text] [Related]
19. Indacaterol-Glycopyrronium for COPD.
Suissa S
N Engl J Med; 2016 Sep; 375(9):897-8. PubMed ID: 27579648
[No Abstract] [Full Text] [Related]
20. Indacaterol-Glycopyrronium for COPD.
Wedzicha JA; Banerji D; Vogelmeier CF
N Engl J Med; 2016 Sep; 375(9):899-900. PubMed ID: 27579647
[No Abstract] [Full Text] [Related]
[Next] [New Search]
